Jinhe Biotechnology Co Ltd
SZSE:002688
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Jinhe Biotechnology Co Ltd
SZSE:002688
|
CN |
|
M
|
Modern Dairies Ltd
BSE:519287
|
IN |
|
N
|
NPD Co Ltd
KOSDAQ:198080
|
KR |
|
C
|
Coeur Mining Inc
LSE:0R0U
|
US |
|
T
|
TravelSky Technology Ltd
F:TVL
|
CN |
|
P
|
Peak Rare Earths Ltd
XBER:M3U
|
AU |
|
Y
|
YW Co Ltd
KOSDAQ:051390
|
KR |
|
K
|
Kaymus Resources Inc
XTSX:KYS.H
|
CA |
|
A
|
AUTO1 Group SE
XBER:AG1
|
DE |
|
Q
|
Qorvo Inc
LSE:0KSJ
|
US |
|
M
|
Medifast Inc
XBER:MDF
|
US |
|
P
|
Pizza Pizza Royalty Corp
OTC:PZRIF
|
CA |
|
Transact Energy Corp
OTC:TEGY
|
US |
|
ITEX Corp
OTC:ITEX
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Jinhe Biotechnology Co Ltd's stock price target?
Not Available
Jinhe Biotechnology Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Jinhe Biotechnology Co Ltd's Revenue forecast?
Projected CAGR
9%
For the last 13 years the
compound annual growth rate for
Jinhe Biotechnology Co Ltd's revenue is
10%.
The projected
CAGR
for the next 2 years is
9%.
What is Jinhe Biotechnology Co Ltd's Operating Income forecast?
Projected CAGR
21%
For the last 13 years the
compound annual growth rate for
Jinhe Biotechnology Co Ltd's operating income is
5%.
The projected
CAGR
for the next 2 years is
21%.
What is Jinhe Biotechnology Co Ltd's Net Income forecast?
Projected CAGR
53%
For the last 13 years the
compound annual growth rate for
Jinhe Biotechnology Co Ltd's net income is
2%.
The projected
CAGR
for the next 2 years is
53%.
